SCHEMBL2428510

SCHEMBL2428510

NCCCCC1CC[CH]CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.58
RAD52 P43351 1/20 0.35
NFKB1 P19838 1/20 0.33
CHRM1 P11229 1/20 0.32
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA3 P07451 2/20 0.32
CA4 P22748 2/20 0.32
CA6 P23280 2/20 0.32
CA5A P35218 2/20 0.32
CA7 P43166 2/20 0.32
CA9 Q16790 2/20 0.32
CA14 Q9ULX7 2/20 0.32
CA5B Q9Y2D0 2/20 0.32
DNM1 Q05193 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
BLM P54132 1/20 0.32
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3026105 0.98 SIGMAR1 (0.61) SIGMAR1RAD52NFKB1CHRM1CA12
SCHEMBL10604014 0.93 SIGMAR1 (0.48) SIGMAR1CYP1A2
SCHEMBL3031607 0.88 SIGMAR1 (0.68) SIGMAR1RAD52POLBCYP1A2
SCHEMBL3027401 0.87 SIGMAR1 (0.71) SIGMAR1RAD52POLBCYP1A2
SCHEMBL3031909 0.87 SIGMAR1 (0.71) SIGMAR1RAD52POLBCYP1A2
SCHEMBL11319456 0.82
SCHEMBL134072 0.82
Hydrochloric Acid SCHEMBL23123533 0.79
SCHEMBL131735 0.79 SIGMAR1 (0.76) SIGMAR1RAD52NFKB1CA12CA1
SCHEMBL129839 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2976086-A1 COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE Millennium Pharmaceuticals, Inc. (US) 2016-01-27 EP disclosed
EP-2968340-A1 COMBINATION OF KINASE INHIBITORS AND USES THEREOF Intellikine, LLC (US) 2016-01-20 EP disclosed
WO-2014151147-A1 COMBINATION OF KINASE INHIBITORS AND USES THEREOF INTELLIKINE, LLC (US) 2014-09-25 WO disclosed
WO-2014153509-A1 COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-09-25 WO disclosed
EP-2704723-A2 TREATMENT OF POLYCYSTIC DISEASE The Regents of the University of California (US) 2014-03-12 EP disclosed
EP-2705181-A1 COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF Intellikine, LLC (US) 2014-03-12 EP disclosed
WO-2012154695-A2 TREATMENT OF POLYCYSTIC DISEASE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-11-15 WO disclosed
WO-2012151562-A1 COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF INTELLIKINE, LLC (US) 2012-11-08 WO disclosed
WO-2012148540-A1 COMBINATION OF KANASE INHIBITORS AND USES THREOF INTELLIKINE, LLC (US) 2012-11-01 WO disclosed
EP-2365750-A1 BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE Intellikine, Inc. (US) 2011-09-21 EP disclosed
EP-2252293-A2 KINASE INHIBITORS AND METHODS OF USE Intellikine, Inc. (US) 2010-11-24 EP disclosed
WO-2010051043-A1 BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE INTELLIKINE, INC. (US) 2010-05-06 WO disclosed
WO-2010051042-A1 BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE INTELLIKINE, INC. (US) 2010-05-06 WO disclosed
WO-2009114870-A2 KINASE INHIBITORS AND METHODS OF USE INTELLIKINE, INC. (US) 2009-09-17 WO disclosed
WO-2009114874-A2 BENZOTHIAZOLE KINASE INHIBITORS AND METHODS OF USE INTELLIKINE, INC. (US) 2009-09-17 WO disclosed